Cell and Gene Outsourcing

  1. Key Requirements For Efficient Scale-Up Of Cell Therapy Products, Chapter One 7/24/2025

    Discover advanced bioreactor systems and expert development services that can help you streamline your process and accelerate your path to clinical or commercial success.

  2. Fulfilling The Promise Of Advanced Therapies And A Noble Cause 7/24/2025

    Examine how a mission-driven partnership is breaking barriers in cell and gene therapy to deliver faster, affordable access to life-changing treatments for underserved global communities.

  3. Modernizing Your Way to Success In Cell And Gene Therapy Manufacturing 7/24/2025

    Cell and gene therapy has evolved from a niche concept to a booming sector in just five years, with over 1,300 companies and growing momentum in innovation, investment, and regulatory approvals.

  4. Overcoming Gene Therapy Cost Roadblocks On The Path To Patients 7/23/2025

    Viral vector-based gene therapies are expanding beyond rare diseases to treat larger populations. Discover how innovations in manufacturing are making these life-changing treatments more accessible.

  5. Together, Let's Sail Toward Success 7/23/2025

    Explore the promise and complexity of gene therapy and see how Cytiva empowers scientists to overcome challenges and accelerate life-changing treatments from lab to patient.

  6. Is Your Pharma Facility Ready For The Next Public Health Crisis? 7/17/2025

    Preventive measures wane as a sense of security resumes. Follow these tips to protect business continuity in the next global health crisis.

  7. A Flexible Mindset For Bridging Between Cell-Based Assay Groups 7/16/2025

    Transferring cell-based assays for biologics starts with defining operator and equipment parameters, positive and negative controls, and a sufficient dynamic range.

  8. Advanced Manufacturing And CDMOs Are Rewriting The CGT Cost Equation 7/16/2025

    Without contract manufacturers, small biotechs often don't stand a chance of reaching commercial production scales, let alone global access for their drugs.

  9. Exploring Outsourcing's Role In CGT Scalability And Affordability 7/16/2025

    CDMOs give therapy developers access to state-of-the-art production platforms and expertise without the massive up-front investment required for in-house manufacturing.

  10. Essential Steps For A Successful Analytical Tech Transfer 7/14/2025

    Biologics tech transfer means sharing up to 20 assays. Miss a step, and you risk delays, bad data, and products stuck in limbo.